Clinical Trials Directory

Trials / Completed

CompletedNCT01579526

A Single Dose Study to Determine the Safety and Pharmacokinetics of FP01 Lozenges in Healthy Volunteers

A Randomized, Single Dose Study to Determine the Safety and Pharmacokinetics of FP01 Lozenges in Healthy Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Avalo Therapeutics, Inc. · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the safety and pharmacokinetics of FP01 in healthy volunteers.

Conditions

Interventions

TypeNameDescription
DRUGFP01comparison of different dosages

Timeline

Start date
2012-04-01
Primary completion
2012-04-01
Completion
2012-05-01
First posted
2012-04-18
Last updated
2012-05-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01579526. Inclusion in this directory is not an endorsement.